相关实验视频
Updated: Jul 1, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
未来的医疗医生没有学习儿童超重和肥胖:澳大利亚五所医学院课程分析
Emma Schwartzkoff1,2, Terri Pikora3, Hannah Garven4
1Mid North Coast Local Health District, Health Promotion, Port Macquarie Community Health, Port Macquarie, NSW 2444 Australia.
Medical science educator
|March 9, 2026
概括
澳大利亚的医学院课程显示,儿童超重和肥胖教育存在重大差距. 加强这种培训对于未来的医生来说至关重要,以应对这一公共卫生挑战.
科学领域:
- 医疗教育 医学教育
- 儿科公共卫生 儿科公共卫生
- 肥胖研究 肥胖研究
背景情况:
- 在全球范围内,儿童超重和肥胖率正在增加.
- 这些情况对儿童的健康有重大,长期的影响.
- 有效的管理需要在小儿肥胖方面接受过培训的医疗保健专业人员.
研究的目的:
- 评估澳大利亚医学院课程中关于儿童超重和肥胖的内容程度.
- 确定当前关于儿科肥胖的医疗培训中的具体差距.
- 倡导医疗课程中改善和标准化肥胖教育.
主要方法:
- 澳大利亚五所医学院课程的内容分析.
- 关注与儿童超重和肥胖相关的主题的包容性和深度.
- 对课程结构的定性评估,并强调儿童肥胖症.
主要成果:
- 在儿童超重和肥胖的报道中发现了重大缺陷.
- 儿童肥胖的预防,诊断和管理等关键领域得到了不充分的解决.
- 在所有学校中,缺乏一致和结构化的肥胖教育方法是显而易见的.
结论:
- 目前的医学课程不足以为未来的医生准备应对日益严重的儿童肥胖问题.
- 对儿童超重和肥胖问题进行全面和综合教育至关重要.
- 医学院必须修改课程,以确保毕业生有能力有效和敏感地处理这项公共卫生问题.
相关概念视频
Models of Health Promotion and Illness Prevention I
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Models of Health Promotion and Illness Prevention II
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
The agent-host-environment model states that disease results from...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

